Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Authors:
  • JKJohn Kastelein
    John Kastelein
  • WKWolfgang Koenig
    Wolfgang Koenig
  • JGJacques Genest
    Jacques Genest
  • ALAlberto Lorenzatti
    Alberto Lorenzatti
  • JVJohn Varigos
    John Varigos
  • PSPeter Siostrzonek
    Peter Siostrzonek

Abstract
No abstract available

This publication has 22 references indexed in Scilit: